These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28925725)

  • 1. Light-sensitive drugs in topical formulations: stability indicating methods and photostabilization strategies.
    Ioele G; Tavano L; Luca M; Muzzalupo R; Mancuso A; Ragno G
    Future Med Chem; 2017 Oct; 9(15):1795-1808. PubMed ID: 28925725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photostability Issues in Pharmaceutical Dosage Forms and Photostabilization.
    Janga KY; King T; Ji N; Sarabu S; Shadambikar G; Sawant S; Xu P; Repka MA; Murthy SN
    AAPS PharmSciTech; 2018 Jan; 19(1):48-59. PubMed ID: 28905241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability-Indicating Methods for NSAIDs in Topical Formulations and Photoprotection in Host-Guest Matrices.
    Ioele G; Tavano L; Muzzalupo R; De Luca M; Ragno G
    Mini Rev Med Chem; 2016; 16(8):676-82. PubMed ID: 26156542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photostabilization strategies of photosensitive drugs.
    Coelho L; Almeida IF; Sousa Lobo JM; Sousa E Silva JP
    Int J Pharm; 2018 Apr; 541(1-2):19-25. PubMed ID: 29438725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photostability and ex-vivo permeation studies on diclofenac in topical niosomal formulations.
    Ioele G; Tavano L; De Luca M; Ragno G; Picci N; Muzzalupo R
    Int J Pharm; 2015 Oct; 494(1):490-7. PubMed ID: 26307262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodegradation of Anti-Inflammatory Drugs: Stability Tests and Lipid Nanocarriers for Their Photoprotection.
    Ioele G; Grande F; De Luca M; Occhiuzzi MA; Garofalo A; Ragno G
    Molecules; 2021 Oct; 26(19):. PubMed ID: 34641532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The difficulties for a photolabile drug in topical formulations: the case of diclofenac.
    Ioele G; De Luca M; Tavano L; Ragno G
    Int J Pharm; 2014 Apr; 465(1-2):284-90. PubMed ID: 24491531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodegradation of (-)-epigallocatechin-3-gallate in topical cream formulations and its photostabilization.
    Bianchi A; Marchetti N; Scalia S
    J Pharm Biomed Anal; 2011 Dec; 56(4):692-7. PubMed ID: 21807473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photostabilization of 1,4-dihydropyridine antihypertensives by incorporation into beta-cyclodextrin and liposomes.
    Ragno G; Risoli A; Ioele G; Cione E; De Luca M
    J Nanosci Nanotechnol; 2006; 6(9-10):2979-85. PubMed ID: 17048507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of in-use photostability: proposed guidance for photostability testing and labeling to support the administration of photosensitive pharmaceutical products, part 1: drug products administered by injection.
    Baertschi SW; Clapham D; Foti C; Jansen PJ; Kristensen S; Reed RA; Templeton AC; Tønnesen HH
    J Pharm Sci; 2013 Nov; 102(11):3888-99. PubMed ID: 24009146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting the photostability characteristics of active pharmaceutical ingredients using electron paramagnetic resonance spectroscopy.
    Williams HE; Claybourn M
    Drug Dev Ind Pharm; 2012 Feb; 38(2):200-8. PubMed ID: 21806507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of In-Use Photostability: Proposed Guidance for Photostability Testing and Labeling to Support the Administration of Photosensitive Pharmaceutical Products, Part 3. Oral Drug Products.
    Allain L; Baertschi SW; Clapham D; Foti C; Lantaff WM; Reed RA; Templeton AC; Tønnesen HH
    J Pharm Sci; 2016 May; 105(5):1586-1594. PubMed ID: 27056630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photostability of barnidipine in combined cyclodextrin-in-liposome matrices.
    Ioele G; De Luca M; Ragno G
    Future Med Chem; 2014 Jan; 6(1):35-43. PubMed ID: 24358946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Niosomes as a propitious carrier for topical drug delivery.
    Hamishehkar H; Rahimpour Y; Kouhsoltani M
    Expert Opin Drug Deliv; 2013 Feb; 10(2):261-72. PubMed ID: 23252629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing impact of manufacturing and package configurations to photosensitive compounds.
    Carvalho TC; Escotet ML; Lin J; Sprockel OL
    Drug Dev Ind Pharm; 2016; 42(6):936-44. PubMed ID: 26460067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved tretinoin photostability in a topical nanomedicine replacing original liquid suspension with spray-dried powder with no loss of effectiveness.
    Marchiori MC; Rascovetzki RH; Ourique AF; Rigo LA; Silva CB; Beck RC
    Drug Dev Ind Pharm; 2013 Apr; 39(4):579-86. PubMed ID: 22697376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-Use Photostability Practice and Regulatory Evaluation for Pharmaceutical Products in an Age of Light-Emitting Diode Light Sources.
    Allain LR; Pierce BC; Wuelfing WP; Templeton AC; Helmy R
    J Pharm Sci; 2019 Mar; 108(3):1172-1176. PubMed ID: 30315811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UVA is the major contributor to the photodegradation of tretinoin and isotretinoin: Implications for development of improved pharmaceutical formulations.
    Tashtoush BM; Jacobson EL; Jacobson MK
    Int J Pharm; 2008 Mar; 352(1-2):123-8. PubMed ID: 18093761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How can the challenges faced by nanoparticle-based pulmonary drug formulations be overcome.
    Chow SF; Weng J; Xuan B; Wan KY
    Ther Deliv; 2019 Feb; 10(2):87-89. PubMed ID: 30678543
    [No Abstract]   [Full Text] [Related]  

  • 20. Engineered nanocrystal technology: in-vivo fate, targeting and applications in drug delivery.
    Pawar VK; Singh Y; Meher JG; Gupta S; Chourasia MK
    J Control Release; 2014 Jun; 183():51-66. PubMed ID: 24667572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.